1 minute read

HEALTH DIGEST

Therapeutics program.

Scientists are very good at finding inhibitors for enzymes that are overactive. But they have meager results as far as strengthening interactions that are weak or absent. There are existing examples of drugs that stabilize protein-protein interactions (transplant drugs rapamycin and cyclosporine), but they inhibit the function of the proteins they target, as intended —Quinn

Eastman

“It is very exciting, because this is a clear example of a protein-protein interaction stabilizer that can reactivate the lost function and reestablish tumor-suppressive activity.” dure in the United States and Canada.

During a TAVR procedure, a doctor uses a catheter inserted into a patient’s blood vessel to deliver a prosthetic heart valve, replacing the patient’s impaired valve.

“This threestar rating affirms Emory Saint Joseph’s Hospital as a leader in quality for the TAVR procedure, which is increasingly becoming a top-choice method to treat valve dysfunction in a minimally-invasive way, leading to faster recoveries and better outcomes for our patients,” says George Hanzel, interventional cardiologist and director of the cardiac catheterization lab at the hospital. EHD

This article is from: